Print

St. Renatus LLC Planning Phase 3 Trials, Joins SAFE-BioPharma, LLC  
9/14/2010 12:01:01 PM

FT. LEE, N.J.--(BUSINESS WIRE)--St. Renatus, LLC, which is dedicated to commercialize the world’s first dental anesthetic administered through the nasal cavity, has joined SAFE-BioPharma Association. SAFE-BioPharma manages the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.
//-->